Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Monday's Intraday Session

Gainers

  • Scopus BioPharma (NASDAQ:SCPS) shares rose 72.1% to $1.1 during Monday's regular session. Trading volume for Scopus BioPharma's stock is 3.4 million as of 13:31 EST. This is 1745.6% of its average full-day volume over the last 100 days. The company's market cap stands at $23.2 million.
  • Yumanity Therapeutics (NASDAQ:YMTX) stock rose 47.32% to $1.65. Yumanity Therapeutics's stock is trading at a volume of 4.8 million shares as of 13:31 EST. This is 5342.2% of its average full-day volume over the last 100 days. The company's market cap stands at $17.0 million.
  • GBS (NASDAQ:GBS) shares increased by 37.25% to $1.14. Trading volume for GBS's stock is 5.8 million as of 13:31 EST. This is 253.2% of its average full-day volume over the last 100 days. The company's market cap stands at $16.9 million.
  • Corbus Pharmaceuticals (NASDAQ:CRBP) shares moved upwards by 34.79% to $0.44. Corbus Pharmaceuticals's stock is trading at a volume of 3.6 million shares as of 13:31 EST. This is 303.9% of its average full-day volume over the last 100 days. The company's market cap stands at $55.7 million.
  • Spectrum Pharmaceuticals (NASDAQ:SPPI) stock moved upwards by 33.08% to $1.2. As of 13:31 EST, Spectrum Pharmaceuticals's stock is trading at a volume of 7.0 million, which is 129.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $210.8 million. The company's, Q4 earnings came out 2 days ago.
  • NexGel (NASDAQ:NXGL) shares rose 19.25% to $2.04. As of 13:31 EST, this security is trading at a volume of 186.8K shares, making up 45.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $11.3 million. The company's, Q4 earnings came out today.

Losers

  • Vallon Pharmaceuticals (NASDAQ:VLON) shares declined by 68.7% to $2.33 during Monday's regular session. The current volume of 7.7 million shares is 3570.6% of Vallon Pharmaceuticals's average full-day volume over the last 100 days (last updated at 13:31 EST). The market value of their outstanding shares is at $15.8 million.
  • Allena Pharmaceuticals (NASDAQ:ALNA) shares fell 44.05% to $0.27. As of 13:31 EST, this security is trading at a volume of 14.0 million shares, making up 771.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $23.1 million.
  • Connect Biopharma Hldgs (NASDAQ:CNTB) shares decreased by 23.04% to $3.81. Connect Biopharma Hldgs's stock is trading at a volume of 158.2K shares as of 13:31 EST. This is 61.0% of its average full-day volume over the last 100 days. The company's market cap stands at $219.0 million.
  • Vigil Neuroscience (NASDAQ:VIGL) stock decreased by 21.36% to $8.1. The current volume of 143.8K shares is 83.7% of Vigil Neuroscience's average full-day volume over the last 100 days (last updated at 13:31 EST). The market value of their outstanding shares is at $228.9 million.
  • Immunogen (NASDAQ:IMGN) stock declined by 20.73% to $4.17. Trading volume for this security as of 13:31 EST is 14.2 million, which is 475.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $919.6 million.
  • Sutro Biopharma (NASDAQ:STRO) stock fell 16.19% to $8.13. Trading volume for Sutro Biopharma's stock is 314.0K as of 13:31 EST. This is 53.3% of its average full-day volume over the last 100 days. The company's market cap stands at $377.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.